Literature DB >> 26474913

Parental origin impairment of synaptic functions and behaviors in cytoplasmic FMRP interacting protein 1 (Cyfip1) deficient mice.

Leeyup Chung1, Xiaoming Wang1, Li Zhu1, Aaron J Towers2, Xinyu Cao1, Il Hwan Kim3, Yong-hui Jiang4.   

Abstract

CYFIP1 maps to the interval between proximal breakpoint 1 (BP1) and breakpoint 2 (BP2) of chromosomal 15q11-q13 deletions that are implicated in the Angelman (AS) and Prader-Willi syndrome (PWS). There is only one breakpoint (BP3) at the distal end of deletion. CYFIP1 is deleted in AS patients with the larger class I deletion (BP1 to BP3) and the neurological presentations in these patients are more severe than that of patients with class II (BP2 to BP3) deletion. The haploinsufficiency of CYFIP1 is hypothesized to contribute to more severe clinical presentations in class I AS patients. The expression of CYFIP1 is suggested to be bi-allelic in literature but the possibility of parental origin of expression is not completely excluded. We generated and characterized Cyfip1 mutant mice. Homozygous Cyfip1 mice were early embryonic lethal. However, there was a parental origin specific effect between paternal Cyfip1 deficiency (m+/p-) and maternal deficiency (m-/p+) on both synaptic transmissions and behaviors in hippocampal CA1 synapses despite no evidence supporting the parental origin difference for the expression. Both m-/p+ and m+/p- showed the impaired input-output response and paired-pulse facilitation. While the long term-potentiation and group I mGluR mediated long term depression induced by DHPG was not different between Cyfip1 m-/p+ and m+/p- mice, the initial DHPG induced response was significantly enhanced in m-/p+ but not in m+/p- mice. m+/p- but not m-/p+ mice displayed increased freezing in cued fear conditioning and abnormal transitions in zero-maze test. The impaired synaptic transmission and behaviors in haploinsufficiency of Cyfip1 mice provide the evidence supporting the role of CYFIP1 modifying the clinical presentation of class I AS patients and in human neuropsychiatric disorders.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Parental origin

Mesh:

Substances:

Year:  2015        PMID: 26474913      PMCID: PMC4744651          DOI: 10.1016/j.brainres.2015.10.015

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  63 in total

Review 1.  Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes.

Authors:  R D Nicholls; J L Knepper
Journal:  Annu Rev Genomics Hum Genet       Date:  2001       Impact factor: 8.929

2.  p63 is a p53 homologue required for limb and epidermal morphogenesis.

Authors:  A A Mills; B Zheng; X J Wang; H Vogel; D R Roop; A Bradley
Journal:  Nature       Date:  1999-04-22       Impact factor: 49.962

Review 3.  Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function.

Authors:  Gary J Bassell; Stephen T Warren
Journal:  Neuron       Date:  2008-10-23       Impact factor: 17.173

4.  A cluster of oppositely imprinted transcripts at the Gnas locus in the distal imprinting region of mouse chromosome 2.

Authors:  J Peters; S F Wroe; C A Wells; H J Miller; D Bodle; C V Beechey; C M Williamson; G Kelsey
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

5.  Mice lacking synapsin III show abnormalities in explicit memory and conditioned fear.

Authors:  B Porton; R M Rodriguiz; L E Phillips; J W Gilbert; J Feng; P Greengard; H-T Kao; W C Wetsel
Journal:  Genes Brain Behav       Date:  2009-11-24       Impact factor: 3.449

6.  Altered hippocampal synaptic plasticity in the FMR1 gene family knockout mouse models.

Authors:  Jing Zhang; Lingfei Hou; Eric Klann; David L Nelson
Journal:  J Neurophysiol       Date:  2009-02-25       Impact factor: 2.714

7.  Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice.

Authors:  Aubin Michalon; Michael Sidorov; Theresa M Ballard; Laurence Ozmen; Will Spooren; Joseph G Wettstein; Georg Jaeschke; Mark F Bear; Lothar Lindemann
Journal:  Neuron       Date:  2012-04-12       Impact factor: 17.173

8.  The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP.

Authors:  Ilaria Napoli; Valentina Mercaldo; Pietro Pilo Boyl; Boris Eleuteri; Francesca Zalfa; Silvia De Rubeis; Daniele Di Marino; Evita Mohr; Marzia Massimi; Mattia Falconi; Walter Witke; Mauro Costa-Mattioli; Nahum Sonenberg; Tilmann Achsel; Claudia Bagni
Journal:  Cell       Date:  2008-09-19       Impact factor: 41.582

9.  Large recurrent microdeletions associated with schizophrenia.

Authors:  Hreinn Stefansson; Dan Rujescu; Sven Cichon; Olli P H Pietiläinen; Andres Ingason; Stacy Steinberg; Ragnheidur Fossdal; Engilbert Sigurdsson; Thordur Sigmundsson; Jacobine E Buizer-Voskamp; Thomas Hansen; Klaus D Jakobsen; Pierandrea Muglia; Clyde Francks; Paul M Matthews; Arnaldur Gylfason; Bjarni V Halldorsson; Daniel Gudbjartsson; Thorgeir E Thorgeirsson; Asgeir Sigurdsson; Adalbjorg Jonasdottir; Aslaug Jonasdottir; Asgeir Bjornsson; Sigurborg Mattiasdottir; Thorarinn Blondal; Magnus Haraldsson; Brynja B Magnusdottir; Ina Giegling; Hans-Jürgen Möller; Annette Hartmann; Kevin V Shianna; Dongliang Ge; Anna C Need; Caroline Crombie; Gillian Fraser; Nicholas Walker; Jouko Lonnqvist; Jaana Suvisaari; Annamarie Tuulio-Henriksson; Tiina Paunio; Timi Toulopoulou; Elvira Bramon; Marta Di Forti; Robin Murray; Mirella Ruggeri; Evangelos Vassos; Sarah Tosato; Muriel Walshe; Tao Li; Catalina Vasilescu; Thomas W Mühleisen; August G Wang; Henrik Ullum; Srdjan Djurovic; Ingrid Melle; Jes Olesen; Lambertus A Kiemeney; Barbara Franke; Chiara Sabatti; Nelson B Freimer; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; Ole A Andreassen; Roel A Ophoff; Alexander Georgi; Marcella Rietschel; Thomas Werge; Hannes Petursson; David B Goldstein; Markus M Nöthen; Leena Peltonen; David A Collier; David St Clair; Kari Stefansson
Journal:  Nature       Date:  2008-09-11       Impact factor: 49.962

10.  Genomic analysis of the chromosome 15q11-q13 Prader-Willi syndrome region and characterization of transcripts for GOLGA8E and WHCD1L1 from the proximal breakpoint region.

Authors:  Yong-Hui Jiang; Kekio Wauki; Qian Liu; Jan Bressler; Yanzhen Pan; Catherine D Kashork; Lisa G Shaffer; Arthur L Beaudet
Journal:  BMC Genomics       Date:  2008-01-28       Impact factor: 3.969

View more
  10 in total

1.  A Common CYFIP1 Variant at the 15q11.2 Disease Locus Is Associated with Structural Variation at the Language-Related Left Supramarginal Gyrus.

Authors:  Young Jae Woo; Tao Wang; Tulio Guadalupe; Rebecca A Nebel; Arianna Vino; Victor A Del Bene; Sophie Molholm; Lars A Ross; Marcel P Zwiers; Simon E Fisher; John J Foxe; Brett S Abrahams
Journal:  PLoS One       Date:  2016-06-28       Impact factor: 3.240

2.  Parent-of-Origin Effects in 15q11.2 BP1-BP2 Microdeletion (Burnside-Butler) Syndrome.

Authors:  Kyle W Davis; Moises Serrano; Sara Loddo; Catherine Robinson; Viola Alesi; Bruno Dallapiccola; Antonio Novelli; Merlin G Butler
Journal:  Int J Mol Sci       Date:  2019-03-22       Impact factor: 5.923

3.  Cyfip1 Haploinsufficiency Increases Compulsive-Like Behavior and Modulates Palatable Food Intake in Mice: Dependence on Cyfip2 Genetic Background, Parent-of Origin, and Sex.

Authors:  Richard K Babbs; Jacob A Beierle; Qiu T Ruan; Julia C Kelliher; Melanie M Chen; Ashley X Feng; Stacey L Kirkpatrick; Fabiola A Benitez; Fred A Rodriguez; Johanne J Pierre; Jeya Anandakumar; Vivek Kumar; Megan K Mulligan; Camron D Bryant
Journal:  G3 (Bethesda)       Date:  2019-09-04       Impact factor: 3.154

4.  Differential cell-type-expression of CYFIP1 and CYFIP2 in the adult mouse hippocampus.

Authors:  Yinhua Zhang; Hyae Rim Kang; Kihoon Han
Journal:  Anim Cells Syst (Seoul)       Date:  2019-11-24       Impact factor: 1.815

Review 5.  Rho GTPase Regulators and Effectors in Autism Spectrum Disorders: Animal Models and Insights for Therapeutics.

Authors:  Daji Guo; Xiaoman Yang; Lei Shi
Journal:  Cells       Date:  2020-03-31       Impact factor: 6.600

6.  Smaller Body Size, Early Postnatal Lethality, and Cortical Extracellular Matrix-Related Gene Expression Changes of Cyfip2-Null Embryonic Mice.

Authors:  Yinhua Zhang; Hyojin Kang; Yeunkum Lee; Yoonhee Kim; Bokyoung Lee; Jin Yong Kim; Chunmei Jin; Shinhyun Kim; Hyun Kim; Kihoon Han
Journal:  Front Mol Neurosci       Date:  2019-01-04       Impact factor: 5.639

7.  Behavioral training rescues motor deficits in Cyfip1 haploinsufficiency mouse model of autism spectrum disorders.

Authors:  Sven O Bachmann; Monika Sledziowska; Ellen Cross; Shireene Kalbassi; Sophie Waldron; Fangli Chen; Adam Ranson; Stéphane J Baudouin
Journal:  Transl Psychiatry       Date:  2019-01-21       Impact factor: 6.222

8.  The autism- and schizophrenia-associated protein CYFIP1 regulates bilateral brain connectivity and behaviour.

Authors:  Nuria Domínguez-Iturza; Adrian C Lo; Disha Shah; Marcelo Armendáriz; Anna Vannelli; Valentina Mercaldo; Massimo Trusel; Ka Wan Li; Denise Gastaldo; Ana Rita Santos; Zsuzsanna Callaerts-Vegh; Rudi D'Hooge; Manuel Mameli; Annemie Van der Linden; August B Smit; Tilmann Achsel; Claudia Bagni
Journal:  Nat Commun       Date:  2019-08-01       Impact factor: 14.919

9.  Enhanced Prefrontal Neuronal Activity and Social Dominance Behavior in Postnatal Forebrain Excitatory Neuron-Specific Cyfip2 Knock-Out Mice.

Authors:  Yinhua Zhang; Rim Kang Hyae; Seung-Hyun Lee; Yoonhee Kim; Ruiying Ma; Chunmei Jin; Ji-Eun Lim; Seoyeon Kim; Yeju Kang; Hyojin Kang; Su Yeon Kim; Seok-Kyu Kwon; Se-Young Choi; Kihoon Han
Journal:  Front Mol Neurosci       Date:  2020-10-29       Impact factor: 5.639

10.  Deficiency of the neurodevelopmental disorder-associated gene Cyfip2 alters the retinal ganglion cell properties and visual acuity.

Authors:  Taro Chaya; Hiroshi Ishikane; Leah R Varner; Yuko Sugita; Yamato Maeda; Ryotaro Tsutsumi; Daisuke Motooka; Daisuke Okuzaki; Takahisa Furukawa
Journal:  Hum Mol Genet       Date:  2022-02-21       Impact factor: 6.150

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.